tetano
Editor, Senior Moderator
J Eur Acad Dermatol Venereol
. 2020 Jun 26.
doi: 10.1111/jdv.16777. Online ahead of print.
Acute Acral Cutaneous Manifestations During the COVID-19 Pandemic: A Single Center Experience
Marta Garc?a-Legaz Mart?nez[SUP] 1 [/SUP], ?lvaro Mart?nez-Dom?nech[SUP] 1 [/SUP], Jorge Magdaleno-Tapial[SUP] 1 [/SUP], Cristian Valenzuela-O?ate[SUP] 1 [/SUP], Felipe Partarrieu-Mej?as[SUP] 1 [/SUP], Javier Lorca-Spr?hnle[SUP] 1 [/SUP], Andr?s Casanova-Esquembre[SUP] 1 [/SUP], Amparo P?rez-Ferriols[SUP] 1 [/SUP], V?ctor Alegre-de Miquel[SUP] 1 [/SUP]
Affiliations
Abstract
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), was first reported in China on December 2019. Almost 5 months into the pandemic, little is still known about cutaneous manifestations in COVID-19. In fact, the prevalence of cutaneous signs varies greatly in the literature, ranging from 0.2% to 20.4%. Given their potential association with COVID-19, acral lesions have received special attention worldwide, both in the medical literature and the media. Our aim is to share our experience regarding acral manifestations during this pandemic.
This article is protected by copyright. All rights reserved.
. 2020 Jun 26.
doi: 10.1111/jdv.16777. Online ahead of print.
Acute Acral Cutaneous Manifestations During the COVID-19 Pandemic: A Single Center Experience
Marta Garc?a-Legaz Mart?nez[SUP] 1 [/SUP], ?lvaro Mart?nez-Dom?nech[SUP] 1 [/SUP], Jorge Magdaleno-Tapial[SUP] 1 [/SUP], Cristian Valenzuela-O?ate[SUP] 1 [/SUP], Felipe Partarrieu-Mej?as[SUP] 1 [/SUP], Javier Lorca-Spr?hnle[SUP] 1 [/SUP], Andr?s Casanova-Esquembre[SUP] 1 [/SUP], Amparo P?rez-Ferriols[SUP] 1 [/SUP], V?ctor Alegre-de Miquel[SUP] 1 [/SUP]
Affiliations
- PMID: 32589301
- DOI: 10.1111/jdv.16777
Abstract
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), was first reported in China on December 2019. Almost 5 months into the pandemic, little is still known about cutaneous manifestations in COVID-19. In fact, the prevalence of cutaneous signs varies greatly in the literature, ranging from 0.2% to 20.4%. Given their potential association with COVID-19, acral lesions have received special attention worldwide, both in the medical literature and the media. Our aim is to share our experience regarding acral manifestations during this pandemic.
This article is protected by copyright. All rights reserved.